Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.

Blood - 22 Oct 2009

Stumpf Anita N, van der Meijden Edith D, van Bergen Cornelis A M, Willemze Roel, Falkenburg J H Frederik, Griffioen Marieke

Abstract excerpt

Potent graft-versus-leukemia (GVL) effects can be mediated by donor-derived T cells recognizing minor histocompatibility antigens (mHags) in patients treated with donor lymphocyte infusion (DLI) for relapsed hematologic malignancies after HLA-matched allogeneic stem cell transplantation (alloSCT). Donor-derived T cells, however, may not only induce GVL, but also mediate detrimental graft-versus-host disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Focal Adhesion Kinase 2
Share to Graft vs Host Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hematopoietic System

Share to Lectins, C-Type

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Methylenetetrahydrofolate Dehydrogenase (NADP)

Share to Minor Histocompatibility Antigens

Share to Transplantation, Homologous

Source

Identifiers

PMID: 19706888
DOI: 10.1182/blood-2009-03-208017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.PMID 19706888Read ↗

Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity.Semantic proximity Read ↗

Identification of phosphatidylinositol 4-kinase type II β as HLA class II-restricted target in graft versus leukemia reactivitySemantic proximity Read ↗

Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.Semantic proximity Read ↗

Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemiaSemantic proximity Read ↗

Associations of Minor Histocompatibility Antigens with Clinical Outcomes Following Allogeneic Hematopoietic Cell TransplantationSemantic proximity Read ↗

Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.Semantic proximity Read ↗

HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusionSemantic proximity Read ↗

Computational modeling and confirmation of leukemia-associated minor histocompatibility antigensSemantic proximity Read ↗

Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen.Semantic proximity Read ↗

Expanding the immunotherapeutic potential of minor histocompatibility antigens.Semantic proximity Read ↗

High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning.Semantic proximity Read ↗

HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.